Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
4
×
startups
vc
deals
life sciences
new york blog main
san francisco blog main
biotech
boston blog main
boston top stories
healthtech
new york top stories
san diego blog main
san francisco top stories
software
4490 ventures
acetylon pharmaceuticals
agro biosciences
agtech products
agtechfood
ambys medicines
angel investors
apps
arboretum ventures
arm & hammer animal nutrition
azacitidine
bertelsmann
beta-thalassemia
boston
bram daelemans
cell therapy
church & dwight
cleantech
connected devices
connecture
constellation pharmaceuticals
cream city venture capital
cultivation capital
cybersecurity
What
new
4
×
startup
4
×
based
biotech
medicines
technology
today
aiming
aims
ambys
ann
announced
approach
approval
arbor
big
bigger
called
capital
control
deadly
deal
deals
debuted
debuts
developed
developing
diseases
drugs
epigenetic
epigenetics
exits
eye
fda
field
fifth
flagship’s
formed
founders
funding
Language
unset
Current search:
new
×
startup
×
" national top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
